Addressing Palliative Care Needs Among Intensive Care Unit Family Members (ICUconnect)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03506438|
Recruitment Status : Not yet recruiting
First Posted : April 24, 2018
Last Update Posted : February 7, 2019
|Condition or disease||Intervention/treatment||Phase|
|Critical Illness Family Members Psychological Distress Informal Caregivers Palliative Care||Behavioral: Needs-focused mobile app Other: Usual care||Not Applicable|
The quality of palliative care is highly variable in an intensive care unit (ICU) setting. These markers of poor quality are even more common among Black patients and families than among Whites. To address these challenges, the investigators developed a mobile app that allows families to both give and receive information relevant to palliative care and for ICU clinicians to visualize patient/family data and therefore better support them.
To determine the effect of this intervention,the investigators propose to conduct a randomized clinical trial (RCT) comparing the intervention to usual care to address four specific aims: (1) Using a cluster randomized clinical trial, determine the effect of the intervention vs usual care on unmet needs [as measured by the NEST scale] and patient-centered care [as measured by the IPC scale], (2) Determine the impact of the intervention on unmet needs and patient-centered care based across different racial groups, and (3) Explore family member and clinician experiences with intervention using mixed methods to understand mechanisms within unique case contexts [exploratory aim]. The investigators hypothesize that compared to usual care, PCneeds will reduce family members' unmet needs, increase the patient-centeredness care, and reduce hospital length of stay overall--though the magnitude of effect will be greater among Blacks compared to Whites.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||240 participants|
|Intervention Model:||Parallel Assignment|
|Intervention Model Description:||Unit of randomization is the ICU clinician. We anticipate 15 clinicians for intervention and 15 for control. Therefore each clinician will likely have 6-12 family members each.|
|Masking:||Double (Investigator, Outcomes Assessor)|
The electronic study data system login/password arrangement will not allow any investigator to ascertain treatment group.
The study data system will automatically send links to study surveys for participant self-completion, and therefore outcomes assessors will be blinded to the majority of post-randomization data collection.
|Primary Purpose:||Supportive Care|
|Official Title:||Addressing Palliative Care Needs Among Intensive Care Unit Family Members|
|Estimated Study Start Date :||February 18, 2019|
|Estimated Primary Completion Date :||December 2021|
|Estimated Study Completion Date :||December 2021|
Experimental: Mobile app group
Clinicians and family members will receive access to versions of the needs-focused mobile app that differ in content.
Behavioral: Needs-focused mobile app
A mobile web app designed to assist both ICU clinicians in addressing patient/family needs and families in reporting their unmet needs.
Placebo Comparator: Usual care
Usual ICU care
Other: Usual care
Usual ICU care
- Change in the Needs; Existential concerns; Symptoms; and Therapeutic interaction (NEST) scale total score [ Time Frame: Time 1 (baseline), Time 2 (target ~3 days post-randomization), Time 3 (target ~1 week post-randomization), and Time 4 (3 months post-randomization) ]A palliative care needs instrument. Scores range from 0 (no needs) to 130 (higher needs)
- Change in Patient Health Questionnaire 9-Item scale (PHQ-9) [ Time Frame: Time 1 (baseline), Time 2 (target ~3 days post-randomization), and Time 4 (3 months post-randomization) ]A depression symptoms instrument. Scores range from 0 (no depression symptoms) to 27 (higher depression symptoms)
- Change in Generalized Anxiety Disorder 7-Item scale (GAD-7) [ Time Frame: Time 1 (baseline), Time 2 (target ~3 days post-randomization), and Time 4 (3 months post-randomization) ]An anxiety symptoms instrument. Scores range from 0 (no anxiety symptoms) to 21 (higher anxiety symptoms)
- Change in Post-Traumatic Stress Symptom (PTSS) inventory [ Time Frame: Time 1 (baseline) and Time 4 (3 months post-randomization) ]A post-traumatic stress disorder symptom instrument. Scores range from 10 (low PTSD symptoms) to 70 (higher PTSD symptoms)
- Change in goal concordant care [ Time Frame: Time 1 (baseline) and Time 2 (target ~3 days post-randomization) ]A measure of the alignment between patient values and treatments received. This is a dichotomous scale; care is either concordant or discordant.
- Post-randomization hospital length of stay [ Time Frame: Across the entire hospitalization after randomization (approximately 2 weeks) ]A measure of hospital days after randomization
- Post-randomization intensive care unit length of stay [ Time Frame: Across the entire hospitalization after randomization (approximately 2 weeks) ]A measure of intensive care unit days after randomization
- Change in Interpersonal Processes of Care (IPC) 18-Item Short Form Scale [ Time Frame: Baseline (at time of randomization) and ~3 days post-randomization ]A measure of the interpersonal aspects of care. We will use the Communication (elicited concerns), Decision Making, and Discriminated due to race/ethnicity subscales. Scores will be evaluated primarily by subscales, though also a summary measure of these subscales.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03506438
|Contact: Mary Key, MPHfirstname.lastname@example.org|
|Contact: Christopher Cox, MDemail@example.com|
|United States, North Carolina|
|Duke University||Not yet recruiting|
|Durham, North Carolina, United States, 27710|
|Principal Investigator: Christopher E Cox, MD|